(Q43279655)

English

Glucocorticoid treatment restores the impaired suppressive function of regulatory T cells in patients with relapsing-remitting multiple sclerosis

scientific article published in October 2009

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

18 November 2017

Glucocorticoid treatment restores the impaired suppressive function of regulatory T cells in patients with relapsing-remitting multiple sclerosis (English)

1 reference

Europe PubMed Central

18 November 2017

multiple sclerosis

0 references

relapsing-remitting multiple sclerosis

0 references

author name string

L Xu

1

1 reference

Europe PubMed Central

18 November 2017

Z Xu

2

1 reference

Europe PubMed Central

18 November 2017

M Xu

3

1 reference

Europe PubMed Central

18 November 2017

publication date

1 October 2009

1 reference

Europe PubMed Central

18 November 2017

Clinical and Experimental Immunology

1 reference

Europe PubMed Central

18 November 2017

158

1 reference

Europe PubMed Central

18 November 2017

1

1 reference

Europe PubMed Central

18 November 2017

26-30

1 reference

Europe PubMed Central

18 November 2017

The role of regulatory T cells in multiple sclerosis

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2759055

27 August 2018

Multiple sclerosis: a complicated picture of autoimmunity.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2759055

27 August 2018

Prevalence of newly generated naive regulatory T cells (Treg) is critical for Treg suppressive function and determines Treg dysfunction in multiple sclerosis.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2759055

27 August 2018

Treatment-enhanced CD4+Foxp3+ glucocorticoid-induced TNF receptor family related high regulatory tumor-infiltrating T cells limit the effectiveness of cytokine-based immunotherapy

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2759055

27 August 2018

Increased frequency of CD4+ CD25+ regulatory T cells in the cerebrospinal fluid but not in the blood of multiple sclerosis patients.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2759055

27 August 2018

Reduced suppressive effect of CD4+CD25high regulatory T cells on the T cell immune response against myelin oligodendrocyte glycoprotein in patients with multiple sclerosis.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2759055

27 August 2018

Loss of functional suppression by CD4+CD25+ regulatory T cells in patients with multiple sclerosis

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2759055

27 August 2018

Immunopathogenesis of the multiple sclerosis lesion

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2759055

27 August 2018

Decreased 4-1BB expression on CD4+CD25 high regulatory T cells in peripheral blood of patients with multiple sclerosis

1 reference

https://pubmed.ncbi.nlm.nih.gov/19737227

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Glucocorticoid treatment reduces T-bet and pSTAT1 expression in mononuclear cells from relapsing remitting multiple sclerosis patients

1 reference

https://pubmed.ncbi.nlm.nih.gov/19737227

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Correlation of myelin basic protein-like material in cerebrospinal fluid of multiple sclerosis patients with their response to glucocorticoid treatment

1 reference

https://pubmed.ncbi.nlm.nih.gov/19737227

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

[Multiple sclerosis and regulatory cells]

1 reference

https://pubmed.ncbi.nlm.nih.gov/19737227

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Secondary progressive in contrast to relapsing-remitting multiple sclerosis patients show a normal CD4+CD25+regulatory T-cell function and FOXP3 expression

1 reference

https://pubmed.ncbi.nlm.nih.gov/19737227

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Circulating dendritic cells subsets and regulatory T-cells at multiple sclerosis relapse: differential short-term changes on corticosteroids therapy

1 reference

https://pubmed.ncbi.nlm.nih.gov/19737227

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

[Revision of McDonald's new diagnostic criteria for multiple sclerosis]

1 reference

https://pubmed.ncbi.nlm.nih.gov/19737227

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Similar sensitivity of regulatory T cells towards CD95L-mediated apoptosis in patients with multiple sclerosis and healthy individuals

1 reference

https://pubmed.ncbi.nlm.nih.gov/19737227

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Interferon beta-1a therapy enhances CD4+ regulatory T-cell function: an ex vivo and in vitro longitudinal study in relapsing-remitting multiple sclerosis

1 reference

https://pubmed.ncbi.nlm.nih.gov/19737227

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1111/J.1365-2249.2009.03987.X

1 reference

Europe PubMed Central

18 November 2017

0 references

1 reference

Europe PubMed Central

18 November 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q43279655&oldid=1985525618"